Luigi Mangione expected to plead guilty in federal stalking case related to health insurance CEO killing: Report

• Mangione is scheduled to appear before Judge Margaret Garnett on Friday for a pretrial conference requested jointly by prosecutors and defense lawyers on Tuesday
• Two federal counts including murder during stalking (which carried a possible death penalty) were dismissed in January; two remaining stalking counts each carry maximum life sentences
• Defense attorneys are expected to argue that a federal guilty plea would bar state murder prosecution under New York's double jeopardy law, with state jury selection scheduled for September 8

Summary: Luigi Mangione Expected to Plead Guilty in Federal Stalking Case

Key Development:

Luigi Mangione is expected to plead guilty Friday in his federal criminal case related to the killing of UnitedHealthcare CEO Brian Thompson in December 2024. The guilty plea would address federal stalking charges connected to Thompson's fatal shooting outside Manhattan's Hilton Hotel on Sixth Avenue.

Legal Status:

• Federal pretrial conference scheduled Friday before Judge Margaret Garnett in U.S. District Court, Manhattan
• Faces two federal counts: interstate stalking resulting in death and stalking through interstate facilities resulting in death
• Each federal count carries a maximum life sentence
• Separately charged with murder in New York state court; jury selection scheduled for September 8
• Federal trial currently scheduled for January 2026

Legal Strategy:

If Mangione pleads guilty federally, his attorneys reportedly plan to argue against state murder prosecution based on New York's double jeopardy law, according to The New York Times.

Background:

Thompson, age 50, was CEO of the largest health insurer in the United States when killed while walking to an investors' event for parent company UnitedHealth Group in December 2024.

Prior Developments:

Judge Garnett dismissed two federal counts in January, including one murder charge that carried potential death penalty exposure.

Market Impact:

While primarily a criminal justice matter, the case involves the CEO of America's largest health insurer and has drawn significant attention to the healthcare industry. Neither prosecutors nor defense attorneys have officially confirmed the expected guilty plea.